Literature DB >> 3800343

Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.

P A Colaizzi, A A Coniglio, W J Poynor, N Vishniavsky, H T Karnes, R E Polk.   

Abstract

Mezlocillin was previously reported to exhibit dose-dependent pharmacokinetics. These reports suggest that it may be possible to administer a relatively large dose at a longer interval than is usual and still achieve therapeutic concentrations in serum. In a randomized, crossover study, we compared concentrations of mezlocillin in serum after a single dose and at steady state in 12 healthy volunteers who received 4 g every 6 h and 5 g every 8 h. A slight, but statistically significant, dose-dependent effect was observed upon the area under the concentration-time curve and total body clearance. No accumulation was observed with either schedule. Although concentrations in serum were higher after the 5-g dose, the more frequent administration of the 4-g dose schedule produced serum concentrations above the MIC for susceptible bacteria for a greater portion of the day. In the absence of clear guidelines from human studies which relate serum concentrations to clinical response, the available data indicate that the more frequent dosage schedule is appropriate for severe infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800343      PMCID: PMC176512          DOI: 10.1128/AAC.30.5.675

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

Review 2.  Current practices in antimicrobial dosing.

Authors:  H C Neu
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

3.  Theory and applications of pulse dosing: a summary of the symposium.

Authors:  W M Kirby; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

4.  A pharmacokinetic program for TI-59.

Authors:  F Nielsen-Kudsk
Journal:  J Pharmacol Methods       Date:  1980-06

5.  Pharmacokinetics of mezlocillin in healthy volunteers.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

6.  Clinical pharmacology of a new ureidopenicillin: Bay K 49999.

Authors:  H Lode; W Tomas; P Koeppe; J Wagner
Journal:  Chemotherapy       Date:  1980       Impact factor: 2.544

7.  Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.

Authors:  N Frimodt-Möller; S Maigaard; R D Toothaker; R W Bundtzen; M V Brodey; W A Craig; P G Welling; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

8.  Controversies in antimicrobial therapy: critical analysis of clinical trials.

Authors:  R E Polk; C D Hepler
Journal:  Am J Hosp Pharm       Date:  1986-03

9.  Mezlocillin dose dependent elimination kinetics in renal impairment.

Authors:  G R Aronoff; R S Sloan; R A Stanish; N S Fineberg
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Dosage schedules of antimicrobial agents: a historical review.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
View more
  5 in total

1.  Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.

Authors:  J F Flaherty; S L Barriere; J Mordenti; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

2.  Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.

Authors:  B R Meyers; M H Mendelson; R G Deeter; E Srulevitch-Chin; M T Sarni; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

3.  Pharmacokinetics of the acyclureidopenicillins piperacillin and mezlocillin in the postpartum patient.

Authors:  M G Martens; S Faro; S Feldman; D B Cotton; K Dorman; G D Riddle
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.

Authors:  B R Meyers; P Wilkinson
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

5.  Pharmacokinetics of two multiple-dose mezlocillin regimens.

Authors:  D M Janicke; S W Parker; R F Cafarell; M A Apicella; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.